Company / FCF Margin
ARS Pharmaceuticals, Inc. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-203.1%
FY2025
5-year range
-198136.7% / 14.6%
FY2022-FY2025
Trend
-1494.2%
vs FY2024
Sector context
#99 of 134
Health Care
What the data says
FCF Margin changed -1494% YoY in FY2025, a notable deviation from the 3-year average annual change of -21075%.
Based on SEC 10-K filings.
-203.1% in FY2025 with a 3-year CAGR of +116.8%.
Improved from -198136.7% to -203.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +116.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#99 of 134 in Health CareTop 74% of 134This company -203.1% Sector average -637.8%
▼
+68.1% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 1494.2% year-over-year.
- Currently 434.6pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -203.1% | -1494.2% |
| FY2024 | 14.6% | +100.0% |
| FY2023 | -198136.7% | -61829.3% |
| FY2022 | -319.9% | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026